SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Tripos (TRPS): Will Surge!
TRPS 0.01100.0%Jan 9 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: NANCY JEWETT who wrote (81)5/29/1997 11:18:00 AM
From: Philip H. Lee   of 152
 
Bought a little more TRPS at 17 1/4.
Current quote: Bid 16 3/4, Ask 17 1/4. Last 17 1/4, + 1/2.

Tripos' strong fundamentals appear to be in place, despite all the stock's gyrations this year. Each one of the top 100 pharmaceuticals companies in the world is a Tripos customer. This broad client base should support the fast-growing Accelerated Discovery Services division, which supplies diverse compound libraries and contract research services to the pharmaceutical and biotechnology industries.

The software division's growth appears to have matured somewhat because of higher market saturation. However, if TRPS can come up with a compelling upgrade and get customers to migrate, the company should make a fortune.

1997 EPS estimate at 0.77; 1998 at 0.91. Seasonally weak 1997 Q1 EPS was 0.05. Tripos has a good record of upside earnings surprises, and I consider the company a possible takeover target. My cost basis on TRPS is around 17 3/4, and my 12-month price target is 25. TRPS has about 3.5 million shares outstanding.

Philip

Disclaimer: Invest at your own risk. Information provided for discussion purposes only and not to be construed as investment advice. Do your own research. Information not guaranteed to be accurate.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext